Literature DB >> 16556487

A new thiazinedione from Xanthium strumarium.

Luping Qin1, Ting Han, Huiliang Li, Qiaoyan Zhang, Hanchen Zheng.   

Abstract

A new thiazinedione was isolated from the fruit of Xanthium strumarium. Its structure was elucidated by a combination of spectral methods.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16556487     DOI： 10.1016/j.fitote.2006.02.001

Source DB:  PubMed          Journal:  Fitoterapia        ISSN： 0367-326X            Impact factor:   2.882


  5 in total

1.  Phytochemical compositions and biological activities of essential oil from Xanthium strumarium L.

Authors:  Javad Sharifi-Rad; Seyedeh Mahsan Hoseini-Alfatemi; Majid Sharifi-Rad; Mehdi Sharifi-Rad; Marcello Iriti; Marzieh Sharifi-Rad; Razieh Sharifi-Rad; Sara Raeisi
Journal:  Molecules       Date:  2015-04-17       Impact factor: 4.411

2.  Volatiles Profiling, Allelopathic Activity, and Antioxidant Potentiality of Xanthium Strumarium Leaves Essential Oil from Egypt: Evidence from Chemometrics Analysis.

Authors:  Ahmed Abd El-Gawad; Abdelsamed Elshamy; Abd El-Nasser El Gendy; Ahmed Gaara; Abdulaziz Assaeed
Journal:  Molecules       Date:  2019-02-07       Impact factor: 4.411

3.  In-vitro antioxidant and antibacterial activities of Xanthium strumarium L. extracts on methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  Javad Sharifi Rad; Seyedeh Mahsan Hoseini Alfatemi; Majid Sharifi Rad; Marcello Iriti
Journal:  Anc Sci Life       Date:  2013-10

4.  Caffeoylxanthiazonoside exerts cardioprotective effects during chronic heart failure via inhibition of inflammatory responses in cardiac cells.

Authors:  Bin Yang; Fei Wang; Huili Cao; Guifang Liu; Yuean Zhang; Ping Yan; Bao Li
Journal:  Exp Ther Med       Date:  2017-08-31       Impact factor: 2.447

5.  Apoptotic Effects of Xanthium strumarium via PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.

Authors:  Juyoung Kim; Kyung Hee Jung; Hyung Won Ryu; Doo-Young Kim; Sei-Ryang Oh; Soon-Sun Hong
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-07       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.